| Date Filed | Type | Description |
| 05/17/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| VERNON W ANTHONY (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| FALBERG KATHRYN E (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| BLICKENSTAFF KIM D (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 05/17/2023 |
4
| Bazemore Robert B (Director) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 366,744 options to buy
@ $1.64, valued at
$601.5k
|
|
| 03/02/2023 |
4
| Markel Stacy (Chief People Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 03/02/2023 |
4
| Hung David (President and CEO) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Disposed of 368,408 shares
@ $0
Granted 2,500,000 options to buy
@ $1.94, valued at
$4.9M
|
|
| 03/02/2023 |
4
| Hanley David C. (Chief Technical Operations) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 03/02/2023 |
4
| Fox Jennifer A. (CFO) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 600,000 options to buy
@ $1.94, valued at
$1.2M
|
|
| 03/02/2023 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 400,000 options to buy
@ $1.94, valued at
$776k
|
|
| 03/02/2023 |
4
| Liu Dongfang (Chief Medical Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 03/02/2023 |
4
| Hattersley Gary (Chief Scientific Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.94, valued at
$970k
|
|
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2022 |
4
| Wentworth Kerry (Chief Regulatory Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 252,000 options to buy
@ $2.93, valued at
$738.4k
|
|
| 08/31/2022 |
4
| Markel Stacy (Chief People Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 450,000 options to buy
@ $2.93, valued at
$1.3M
|
|
| 08/31/2022 |
4
| Liu Dongfang (Chief Medical Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 315,000 options to buy
@ $2.93, valued at
$923k
|
|
| 08/31/2022 |
4
| Hattersley Gary (Chief Scientific Officer) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 400,000 options to buy
@ $2.93, valued at
$1.2M
|
|
| 08/31/2022 |
4
| Hanley David C. (Chief Technical Operations) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 450,000 options to buy
@ $2.93, valued at
$1.3M
|
|
| 08/31/2022 |
4
| Fox Jennifer A. (CFO) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Granted 480,000 options to buy
@ $2.93, valued at
$1.4M
|
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/28/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/28/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/28/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/28/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/28/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2022 |
4
| Omega Fund V, L.P. (10% Owner) has filed a Form 4 on Nuvation Bio Inc.|
Txns:
| Sold 2,500,000 shares
@ $5.6, valued at
$14M
|
|
|